Eosinophilic pneumonia prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
== Prevention of eosinophilic pneumonia == | == Prevention of eosinophilic pneumonia == | ||
* Relapses occur in more than half the patients while decreasing or after stopping corticosteroids. | * [[Relapse|Relapses]] occur in more than half the patients while decreasing or after stopping [[corticosteroids]]. | ||
* Relapses typically can be treated with a dose of 20 mg per day of prednisone. | * Relapses typically can be treated with a dose of 20 mg per day of [[Prednisone|prednisone.]] | ||
* Clinical and functional follow-up is necessary. | * Clinical and functional follow-up is necessary. | ||
* | * Patients should be informed about the role of [[tobacco]] in the disease process and should be encouraged to quit. | ||
== References == | == References == | ||
Revision as of 20:27, 13 February 2018
Overview
Prevention of eosinophilic pneumonia
- Relapses occur in more than half the patients while decreasing or after stopping corticosteroids.
- Relapses typically can be treated with a dose of 20 mg per day of prednisone.
- Clinical and functional follow-up is necessary.
- Patients should be informed about the role of tobacco in the disease process and should be encouraged to quit.
References
|
Eosinophilic pneumonia Microchapters |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Eosinophilic pneumonia prevention On the Web |
|
American Roentgen Ray Society Images of Eosinophilic pneumonia prevention |
|
Risk calculators and risk factors for Eosinophilic pneumonia prevention |